Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(6 sites)
United States
Florida Cancer Specialists, Lake Mary, Florida Florida Cancer Specialists, Sarasota, Florida The Linder Research Center at The Christ Hospital, Cincinnati, Ohio SCRI Oncology Partners, Nashville, Tennessee Tennessee Oncology, PLLC, Nashville, Tennessee The University of Texas MD Anderson Cancer Center, Houston, Texas